Thedruglabel already features a boxedwarning stating that leflunomide is contraindicated for pregnant womenand for womenof childbearing potential not using reliable contraception.
Because of the high risk of oral clefts in fetuses exposed to topiramate, women should have a negative pregnancy test before starting Qsymia and every month while taking the drug, in addition to using contraception.